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We report a case of acute severe hepatitis with Mycoplasma
pneumoniae (M. pneumoniae) infection and transient depres-
sion of multiple coagulation factors. A 5-year-old boy, previously
healthy, was admitted with pneumonia. M. pneumoniae
infection was confirmed by serology testing. Liver enzymes
were elevated on admission without any past medical history.
After treatment with azithromycin for 3 days, pneumonia
improved, but the hepatitis was acutely aggravated. Partial
thromboplastin time (PTT) was prolonged and depression of
multiple coagulation factors developed. Liver biopsy revealed
features consistent with acute hepatitis. A week later, liver
enzymes were nearly normalized spontaneously. Normaliza-
tion of prolonged PTT and coagulation factors were also
observed several months later. This may be the first case of
transient depression of multiple coagulation factors associated
with M. pneumoniae infection.
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INTRODUCTION
Mycoplasma pneumoniae (M. pneumoniae) is a well
known cause of childhood lower respiratory tract
infections, reaching up to 40% of community-
acquired pneumonia.
1 One recent epidemiologic
data showed 6 epidemic peaks at 3- 4 years interval
over 18 years in Korean children.
2 M. pneumoniae
infection is also known for its extrapulmonary
manifestations. Nausea, vomiting, and abdominal
pain are the most common symptoms for ex-
trapulmonary manifestations in Korea.
3 Hepatitis,
hematuria, skin rash, gastroenteritis, and myoperi-
carditis were reported in some cases.
4 Gastro-
intestinal manifestations, such as gastroenteritis,
acute and chronic hepatitis, and pancreatitis have
been reported.
4,5 However, severe hepatitis with
depressed coagulation factors in children with M.
pneumoniae infection has rarely been reported. We
report a child with acute severe hepatitis with M.
pneumoniae infection, accompanied with depressed
multiple coagulation factors.
CASE REPORT
A 5-year-old boy presented with fever and
cough for 6 days. He also developed anorexia and
lethargy, and then was admitted to Inha University
Hospital. Past medical history included atopic
dermatitis during infancy. Hepatitis B vaccination
was administered as scheduled. Six months prior
to admission at a routine health check up, the
serum liver enzymes were normal. The patient had
no history of a bleeding tendency. There was no
family history of hepatitis or liver disease, but the
patient had a younger brother with extrinsic
asthma.
The patient had fever, cough and nasal ob-
struction for 6 days. He had abdominal pain, but
no vomiting or diarrhea. On admission, he
appeared sick. His heart rate was 100/min, respira-
tory rate 24/min and body temperature 38.7°C.
Inspiratory crackles were auscultated at both lung
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fields. The liver was slightly enlarged and palpated
2 cm below costal margin. The spleen was not pal-
pable. An erythematous papular rash was noted
on both extremities.
Chest X-ray showed diffuse bronchopneumonia
in both lungs (Fig. 1). The abdominal sonography
showed hepatomegaly with wall thickening of
gallbladder. The laboratory tests showed Hb 12.2
g/dL, Hct 35.2%, WBC 4,300/mm
3 with 49% neu-
trophil, 32% lymphocytes, and platelets 237,000/
mm
3. The serology testing for M. pneumoniae IgM
class antibody titer was 4,377 Units/mL (normal
range: < 770 Units/mL). The bedside cold agglu-
tinin test was positive. The specific antibody test
was done by the ELISA method (Immuno Well,
GenBio, San Diego, CA, USA). The alanine amino-
transferase (ALT) was 100 IU/L and aspartate
aminotransferase (AST) 169 IU/L. The total biliru-
bin was 0.5 mg/dL and the direct bilirubin 0.3
mg/dL. The total protein was 6.2 g/dL, albumin
3.5 g/dL, ammonia 81 g/dL, and the C-reactive μ
protein was 1.32 mg/dL.
The patient was treated with azithromycin (10
mg/kg/day) for 3 days. On the fourth hospital
day, he developed abdominal pain at the upper-
right quadrant. Tenderness was noted at the
upper-right quadrant. The liver was markedly
enlarged and was palpated 8 cm below costal
margin, compared to the admission examination.
The liver enzymes increased acutely; AST 2,985
IU/L and ALT 2,725 IU/L. Prothrombin time (PT)
was 15.6 seconds (INR: 1.28) and partial throm-
boplastin time (PTT) was 50.7 seconds (normal
range: 30 - 45 seconds) and increased up to 82.1
seconds a few days later (Fig. 2). The serology
testing for HAV, HBV, HCV, cytomegalovirus,
and Ebstein-Barr virus were negative. Wilson
disease and autoimmune hepatitis were excluded.
Factor VIII was 31.0%, factor IX 23.0%, factor XI
43.0%, and factor XII 42.0%. The PTT mixing test
failed to correct prolonged PTT. A bleeding ten-
dency was not observed. On the eighth hospital
day, a liver biopsy was performed. The hepatic
lobules showed features of acute hepatitis such as
ballooning degeneration, spotty necrosis and in-
creased Kupffer cell activity, consistent with acute
hepatitis, but was unremarkable otherwise (Fig.
3).
A week later, the pneumonia was nearly resolved,
and the liver enzymes were decreased; AST was
51 IU/L and the ALT 237 IU/L. The patient was
discharged in good condition. A week after
discharge, the liver enzymes were normalized;
AST 28 IU/L and ALT 43 IU/L. Several months
later, the coagulation factors were nearly nor-
malized without specific treatment. Factor VIII was
55.0%, Factor IX 65.0%, Factor XI 84.0%, and Factor
XII 41.0%. The PTT mixing test was 38.1 seconds.
Fig. 1. Chest X-ray shows increased bronchial wall
thickening and diffuse infiltration on both lungs.
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The patient is currently being followed up as an
outpatient.
DISCUSSION
M. pneumoniae infection can be associated with
dermatologic, cardiologic, neurologic, hematologic,
and musculoskeletal manifestations.
1,5 Gastrointes-
tinal manifestations including hepatitis, acute
acalculous cholecystitis,
6 and pancreatitis have
been reported.
5 Elevated liver enzymes are fre-
quently observed during M. pneumoniae infection
in children. Lee et al.
7 and Suzuyama et al.
8
reported that 15.2% and 36.2% of patients pre-
senting with serologically confirmed M. pneumoniae
infection, respectively, had an evidence of liver
involvement. Liver involvement was transitory in
these patients, and recovery of liver enzymes to
normal range correlated directly with resolution of
mycoplasma pneumonia, as demonstrated in our
patient.
Most previous case reports showed that liver
involvement of M. pneumoniae infection is chole-
stasis rather than hepatic necrosis.
9,10 Hypoalbu-
minemia, hyperbilirubinemia, and hepatomegaly
are characteristics as signs of hepatobiliary invol-
vement in mycoplasma infections.
11 The rapid
progression of hepatomegaly with exacerbation of
hepatitis was observed in this case. Moreover,
hypoalbuminemia and depressed levels of mul-
tiple coagulation factors produced by the liver
were also observed, but hyperbilirubinemia was
not present in this case. Hyperbilirubinemia usually
occurs as the indirect type because of hemolysis
in mycoplasma infection. While cholestasis is very
rare, some cases of cholestatic hepatitis have been
reported in children.
9 Hepatitis has been reported
in a case with M. pneumoniae-associated multiple
organ involvement.
12 The pathogenesis of M.
pneumoniae-associated hepatitis is unknown. Never-
theless, possible mechanisms include direct inva-
sion of the organisms and autoimmunity including
the production of autoantibodies, such as cold
agglutinins.
13
Liver biopsies have been performed in rare cases
of M. pneumoniae-associated hepatitis, and showed
massive hepatocellular destruction and inflamma-
tory infiltration in one patient,
14 while non-specific,
mild lobular hepatitis has also been reported.
12
Liver biopsies performed on 3 patients showed
hepatic dysfunction with histological findings
consistent with a non-specific reactive hepatitis in
each case.
8 In our case, the liver biopsy showed
severe and acute lobular hepatitis.
It is important to consider that liver toxicity has
been observed with almost every class of medica-
tion. The association of macrolide antibiotics with
cholestatic hepatitis is well known.
15,16 Although
erythromycin, clarithromycin, and other macrolides
were correlated with cholestatic liver injury,
azithromycin was not associated commonly with
Fig. 3. The portal area (A) and hepatic lobule (B) show features of acute hepatitis such as ballooning degeneration, spotty
necrosis and increased Kupffer cell activity (H & E, × 400).
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the development of hepatotoxicity. Azithromycin-
induced hepatotoxicity has been reported infre-
quently only in adults. The usual development and
time course of the liver injury, from the beginning
of azithromycin therapy to the onset of symptoms,
has been reported to be 5 to 10 days.
17,18 In our
patient, azithromycin was administered from the
1st to 3rd hospital day and the aggravation of
acute hepatitis occurred on the 4th hospital day.
Although the possibility remains that azithromycin
was the cause of hepatitis in our patient, this is
less likely, since the liver enzymes were elevated
acutely right after the initiation of azithromycin
therapy.
Our patient showed depressed levels of multiple
coagulation factors as well as acute hepatitis. In
several reports, M. pneumoniae infection can be
associated with transient acquired factor II, VIII,
or X deficiencies with clinical manifestations of
bleeding tendency.
19-21 In our case, coagulation
tests revealed prolonged aPTT and decreased
coagulation factors activity, including factors VIII,
IX, XI, and XII, without any bleeding tendency.
The coagulation tests were monitored regularly,
and showed progressive normalization without
specific treatment. Both the absence of a bleeding
tendency in earlier life and the normalization of
prolonged PTT and coagulation factor activity
suggested that congenital factors deficiency was
not the cause of abnormalities.
There was no prior report in the English medical
literature on the depression of multiple coagula-
tion factors associated with mycoplasma infection.
The pathogenesis of this phenomenon in our
patient is unknown. One possible mechanism is a
consumptive coagulopathy due to hepatic deterio-
ration. The other mechanism is the presence of
circulating inhibitors. It is well established that
mycoplasma infection can cause hemolysis due to
the development of autoantibodies including cold
agglutinins.
22 The presence of circulating inhibitors
specific to coagulation factors is supported by the
PTT mixed with normal plasma that failed to
correct prolonged PTT.
In conclusion, we report the first case of M.
pneumoniae infection in a child presenting with
acute hepatitis and transient depression of multiple
coagulation factors.
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